Terms: = Lymphoma AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Diagnosis
67 results:
1. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin lymphoma.
Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
[No Abstract] [Full Text] [Related]
3.
Choi YJ; Min YK; Lee ST; Choi JR; Shin S
Ann Lab Med; 2024 Jul; 44(4):335-342. PubMed ID: 38145892
[TBL] [Abstract] [Full Text] [Related]
4. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
[TBL] [Abstract] [Full Text] [Related]
5. Characteristics of Molecular Genetic Mutations and Their Correlation with Prognosis in Adolescent and Adult Patients with Acute Lymphoblastic Leukemia.
Sun X; Liu X; Li Y; Shi X; Li Y; Tan R; Jiang Y; Sui X; Ge X; Xu H; Wang X; Fang X
Oncology; 2024; 102(1):85-98. PubMed ID: 37437551
[TBL] [Abstract] [Full Text] [Related]
6. Deciphering the spectrum of cutaneous lymphomas expressing TFH markers.
Donzel M; Trecourt A; Balme B; Harou O; Mauduit C; Bachy E; Guesquières H; Fontaine J; Ortonne N; Perier-Muzet M; Dalle S; Traverse-Glehen A
Sci Rep; 2023 Apr; 13(1):6500. PubMed ID: 37081015
[TBL] [Abstract] [Full Text] [Related]
7. Immunophenotypic and genomic landscape of Richter transformation diffuse large B-cell lymphoma.
El Hussein S; Medeiros LJ; Lyapichev KA; Fang H; Jelloul FZ; Fiskus W; Chen J; Wei P; Schlette E; Xu J; Li S; Kanagal-Shamanna R; Yang H; Tang Z; Thakral B; Loghavi S; Jain N; Thompson PA; Ferrajoli A; Wierda WG; Jabbour E; Patel KP; Dabaja BS; Bhalla KN; Khoury JD
Pathology; 2023 Jun; 55(4):514-524. PubMed ID: 36933995
[TBL] [Abstract] [Full Text] [Related]
8. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
[TBL] [Abstract] [Full Text] [Related]
9. Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review.
Gao L; Lu J; Li J; Hu Y; Lu Y; Du W; Hu S
Int J Hematol; 2023 May; 117(5):781-785. PubMed ID: 36472792
[TBL] [Abstract] [Full Text] [Related]
10. Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.
Favini C; Talotta D; Almasri M; Andorno A; Rasi S; Adhinaveni R; Kogila S; Awikeh B; Schipani M; Boggione P; Mouhssine S; Ghanej J; Al Essa W; Mahmoud AM; Dondolin R; Alessa N; Margiotta Casaluci G; Boldorini R; Gattei V; Gaidano G; Moia R
Br J Haematol; 2022 Sep; 198(6):1016-1022. PubMed ID: 35829664
[TBL] [Abstract] [Full Text] [Related]
11. Identification of MAEL as a promoter for the drug resistance model of iPSCs derived from T-ALL.
Chen X; Wen F; Li Z; Li W; Zhou M; Sun X; Zhao P; Zou C; Liu T
Cancer Med; 2022 Sep; 11(18):3479-3490. PubMed ID: 35488386
[TBL] [Abstract] [Full Text] [Related]
12. Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL.
Simonin M; Schmidt A; Bontoux C; Dourthe MÉ; Lengliné E; Andrieu GP; Lhermitte L; Graux C; Grardel N; Cayuela JM; Huguet F; Arnoux I; Ducassou S; Macintyre E; Gandemer V; Dombret H; Petit A; Ifrah N; Baruchel A; Boissel N; Asnafi V
J Hematol Oncol; 2021 May; 14(1):74. PubMed ID: 33941203
[TBL] [Abstract] [Full Text] [Related]
13. MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemia.
Bardelli V; Arniani S; Pierini V; Pierini T; Di Giacomo D; Gorello P; Moretti M; Pellanera F; Elia L; Vitale A; Storlazzi CT; Tolomeo D; Mastrodicasa E; Caniglia M; Chiaretti S; Ruggeri L; Roti G; Schwab C; Harrison CJ; Almeida A; Pieters T; Van Vlierberghe P; Mecucci C; La Starza R
Genes Chromosomes Cancer; 2021 Jul; 60(7):482-488. PubMed ID: 33611795
[TBL] [Abstract] [Full Text] [Related]
14. Gamma Secretase Inhibitor: Therapeutic Target via NOTCH Signaling in T Cell Acute Lymphoblastic Leukemia.
Kaushik B; Pal D; Saha S
Curr Drug Targets; 2021; 22(15):1789-1798. PubMed ID: 33538669
[TBL] [Abstract] [Full Text] [Related]
15. Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group.
Weinberg OK; Chisholm KM; Ok CY; Fedoriw Y; Grzywacz B; Kurzer JH; Mason EF; Moser KA; Bhattacharya S; Xu M; Babu D; Foucar K; Tam W; Bagg A; Orazi A; George TI; Wang W; Wang SA; Arber DA; Hasserjian RP
Mod Pathol; 2021 Jul; 34(7):1358-1366. PubMed ID: 33526873
[TBL] [Abstract] [Full Text] [Related]
16. Biclonal lymphoproliferative disorders: another association with notch1-mutated chronic lymphocytic leukaemias.
Fogarty H; Dowling A; O'Brien D; Langabeer S; Bacon CL; Flavin R; O'Dwyer M; Hennessy B; O'Leary H; Crotty G; Henderson R; Nolan J; Thornton P; Vandenberghe E; Quinn F
Ir J Med Sci; 2021 Aug; 190(3):1087-1094. PubMed ID: 33068240
[TBL] [Abstract] [Full Text] [Related]
17. Aggressive Langerhans cell histiocytosis following T-cell acute lymphoblastic leukemia.
Jansen C; Dykstra J; Callaway D; Lynch D; Cunningham A; Frohm ML
Pediatr Blood Cancer; 2020 Dec; 67(12):e28704. PubMed ID: 32918521
[TBL] [Abstract] [Full Text] [Related]
18. Single-cell DNA amplicon sequencing reveals clonal heterogeneity and evolution in T-cell acute lymphoblastic leukemia.
Albertí-Servera L; Demeyer S; Govaerts I; Swings T; De Bie J; Gielen O; Brociner M; Michaux L; Maertens J; Uyttebroeck A; De Keersmaecker K; Boeckx N; Segers H; Cools J
Blood; 2021 Feb; 137(6):801-811. PubMed ID: 32812017
[TBL] [Abstract] [Full Text] [Related]
19. Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.
Waanders E; Gu Z; Dobson SM; Antić Ž; Crawford JC; Ma X; Edmonson MN; Payne-Turner D; van de Vorst M; Jongmans MCJ; McGuire I; Zhou X; Wang J; Shi L; Pounds S; Pei D; Cheng C; Song G; Fan Y; Shao Y; Rusch M; McCastlain K; Yu J; van Boxtel R; Blokzijl F; Iacobucci I; Roberts KG; Wen J; Wu G; Ma J; Easton J; Neale G; Olsen SR; Nichols KE; Pui CH; Zhang J; Evans WE; Relling MV; Yang JJ; Thomas PG; Dick JE; Kuiper RP; Mullighan CG
Blood Cancer Discov; 2020 Jul; 1(1):96-111. PubMed ID: 32793890
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.
Lejman M; Włodarczyk M; Zawitkowska J; Kowalczyk JR
BMC Med Genomics; 2020 Apr; 13(1):58. PubMed ID: 32245383
[TBL] [Abstract] [Full Text] [Related]
[Next]